MolNFT v1 · #178725 · protein
Human hemoglobin in complex with nitrosoamphetamine
7JJQ: “Human hemoglobin in complex with nitrosoamphetamine”. X-ray diffraction, 2 ligands (HEM, K7M). MolNFT v1 #178725 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7JJQ
- Type
- protein
- Length
- 568 residues
- Chains
- 4
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P69905, P68871
- Ligands
- HEM, K7M
Structure
x-ray diffraction · 4 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 140 | — | P69905 |
| B | — | protein | 145 | — | P68871 |
| C | — | protein | 139 | — | P69905 |
| D | — | protein | 144 | — | P68871 |
Ligands and binding sites
- HEM · Protoporphyrin IX containing Fe · ligand · 4 copies · chains A, B, C, D
- K7M · (2R)-N-hydroxy-1-phenylpropan-2-amine · ligand · 3 copies · chains B, C, D
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7JJQ · Human Hemoglobin in Complex with Nitrosoamphetamine · the same entry in another collection · chain D against D, TM-score 1.00
- P69905 · AlphaFold monomer V2.0 prediction for hemoglobin subunit alpha (P69905) · a predicted model of the same protein · chain A against A, TM-score 0.99
- P68871 · AlphaFold monomer V2.0 prediction for hemoglobin subunit beta (P68871) · a predicted model of the same protein · chain D against A, TM-score 0.92
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P69905
- Every structure of UniProt P68871
- Elsewhere: RCSB PDB 7JJQ · PDBe 7JJQ · UniProt P69905 · UniProt P68871
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.